UBS Group’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$492K Sell
259,169
-378,576
-59% -$650K ﹤0.01% 6098
2025
Q4
$1.01M Buy
637,745
+318,453
+100% +$668K ﹤0.01% 5565
2025
Q3
$744K Buy
319,292
+70,189
+28% +$133K ﹤0.01% 5802
2025
Q2
$314K Sell
249,103
-333,775
-57% -$328K ﹤0.01% 6403
2025
Q1
$532K Buy
582,878
+186,511
+47% +$242K ﹤0.01% 5806
2024
Q4
$630K Buy
396,367
+239,049
+152% +$481K ﹤0.01% 5677
2024
Q3
$308K Buy
157,318
+50,782
+48% +$104K ﹤0.01% 5550
2024
Q2
$175K Sell
106,536
-301,739
-74% -$964K ﹤0.01% 5761
2024
Q1
$2.1M Buy
408,275
+81,746
+25% +$504K ﹤0.01% 3905
2023
Q4
$1.87M Buy
326,529
+175,023
+116% +$865K ﹤0.01% 3892
2023
Q3
$724K Buy
151,506
+35,628
+31% +$221K ﹤0.01% 4369
2023
Q2
$492K Sell
115,878
-23,877
-17% -$107K ﹤0.01% 4833
2023
Q1
$742K Sell
139,755
-54,896
-28% -$342K ﹤0.01% 4368
2022
Q4
$1.22M Buy
194,651
+145,749
+298% +$1.3M ﹤0.01% 3885
2022
Q3
$515K Buy
48,902
+35,055
+253% +$327K ﹤0.01% 4309
2022
Q2
$75K Sell
13,847
-1,794
-11% -$13.7K ﹤0.01% 5629
2022
Q1
$143K Sell
15,641
-2,293
-13% -$24.2K ﹤0.01% 5635
2021
Q4
$271K Buy
17,934
+8,976
+100% +$175K ﹤0.01% 5440
2021
Q3
$214K Buy
+8,958
New +$219K ﹤0.01% 5263

Other funds holding CRBU